All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...793Next →

hiv & aids news selected from other sources

  • Confidentiality, consent and medical ethics
    How to Keep HIV Cure-Related Trials Ethical: The Benefit/Risk Ratio Challenge
    BMJ Blogs | 23 hours ago

    While high or unknown risks are a mainstay of early-phase trials in areas like cancer research, cure study participants typically have a safe and efficacious alternative to those risks: remaining on antiretrovirals. Can we justify asking patients who are doing well on antiretrovirals to accept the risk and uncertainty of many HIV cure-related trials? If we cannot, we might need to give up on the hope of curing HIV, or of achieving controlled remission.

  • History of HIV and AIDS
    Personal Story: an interview with Gordon Scott
    HIV Scotland | 22 February 2017

    Gordon Scott spent 35 years working in the field of HIV. Read about his early career and the first cases of HIV in Edinburgh during the mid-nineties in this first of a two-part interview.

  • Hepatitis C treatment
    Messi visits Egypt to promote Hepatitis C treatment
    Daily News Egypt | 22 February 2017

    Supported by the Egyptian ministries of tourism and aviation, Prime Pharma started a campaign titled “Tour n’ Cure” to promote tourism treatment in Egypt, with Messi being chosen as ambassador for the campaign worldwide.

  • Hepatitis C treatment
    Deal reduces price of life-saving hepatitis C drugs for Canadians
    The Globe and Mail | 22 February 2017

    Tens of thousands of Canadian patients with mild versions of chronic hepatitis C could soon receive public funding for medications that cure the infection now that the provinces have sealed a deal with three pharmaceutical companies to reduce the cost of the ultra-expensive drugs.

  • New and experimental HIV treatments
    New nano approach could cut dose of leading HIV treatment in half
    University of Liverpool press release | 21 February 2017

    Successful results of a University of Liverpool-led trial that utilised nanotechnology to improve drug therapies for HIV patients has been presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, a leading annual conference of HIV research, clinical practice and progress.

  • Cancer
    HCV Infection Linked to Nonhepatic Cancers in the Elderly
    Infectious Disease Advisor | 21 February 2017

    Hepatitis C virus (HCV) infection may be linked to cancers other than hepatocellular carcinoma (HCC), such as bile duct cancers and diffuse large B-cell lymphoma (DLBCL), according to a study published in Cancer.

  • Hepatitis C symptoms and diagnosis
    HCV Screening Shouldn't Just Focus on At-Risk Populations
    Contagion Live | 21 February 2017

    At the Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle, Washington, researchers from MedStar Health Research Institute in Maryland presented new data on hepatitis C virus (HCV)-positive non-baby boomers.

  • Hepatitis C symptoms and diagnosis
    WHO guidelines on hepatitis B and C testing
    World Health Organization | 21 February 2017

    These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for HBV and HCV, and are intended for use across age groups and populations.

  • Prevention of mother-to-child transmission
    Integrating ART postnatally improves outcomes for mothers, children
    Healio | 21 February 2017

    Integration of ART into maternal and child health services during the postnatal period leads to significant improvements in women’s participation in HIV care and resulting viral suppression, according to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI).

  • Access to medicines and treatment
    How Mike Pence used Obamacare to halt Indiana's HIV outbreak
    Politico | 21 February 2017

    Two years later, the vice president is helping lead the Republican effort to dismantle the program.

← First12345...1287Next →

Conference news

News from the Conference on Retroviruses and Opportunistic Infections (CROI 2017).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.